TRHC - Tabula Rasa HealthCare, Inc.
| Previous Close | 67.99 |
| Open | 68.42 |
| Bid | 64.00 x 800 |
| Ask | 68.87 x 900 |
| Day's Range | 66.92 - 68.99 |
| 52 Week Range | 28.55 - 91.16 |
| Volume | 277,768 |
| Avg. Volume | 290,977 |
| Market Cap | 1.4B |
| Beta (3Y Monthly) | 2.42 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.31 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 85.80 |
- GlobeNewswire•7 days ago
TRHC Commends Centers for Medicare and Medicaid Services on Creation of New Opportunities for Dual Medicaid and Medicare Patients
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, issued a statement commending the Centers for Medicare and Medicaid Services (CMS) on the creation of “Ten Opportunities to Better Serve Individuals Dually Eligible for Medicaid and Medicare.” The opportunities, which were outlined in a letter to state Medicaid directors from Seema Verma, Administrator of CMS, focus on increasing individuals’ access to high quality, integrated healthcare. As mentioned in Ms. Verma’s letter, PACE provides innovative integrated care for dually eligible individuals in a comprehensive service package that supports participants to remain in their community rather than a nursing facility.
- American City Business Journals•11 days ago
Tabula Rasa completes $20M acquisition of Australian medical software company
The seller is an Australian company that has developed software to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs.
- GlobeNewswire•15 days ago
Tabula Rasa HealthCare Completes Acquisition of DoseMe
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced that it completed its acquisition of precision dosing software company DoseMe on January 2, 2019. DoseMe is the developer of DoseMeRx™, an advanced precision dosing tool that helps physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes. DoseMeRx’s precision dosing capabilities will combine with TRHC’s proprietary Medication Risk Mitigation (MRM) technologies to enhance and accelerate medication safety solutions and will be made available to the hospital healthcare system market and internationally.
- Zacks•24 days ago
CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?
CPSI vs. TRHC: Which Stock Is the Better Value Option?
- Simply Wall St.•last month
Should You Be Worried About Insider Transactions At Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders Read More...
- GlobeNewswire•last month
Tabula Rasa HealthCare Appoints Kevin Boesen as Chief Sales Officer
Tabula Rasa HealthCare, Inc. (“TRHC”) (TRHC), a healthcare technology company advancing the field of medication safety, today announced the appointment of Kevin Boesen, PharmD, as Chief Sales Officer. In his new role, Dr. Boesen will be responsible for all direct and channel sales efforts in the United States and Canada, with a focus on expanding the adoption of TRHC’s signature product, MedWise™, into health plans, healthcare systems, Programs of All-Inclusive Care for the Elderly and other financially at-risk healthcare organizations.
- American City Business Journals•2 months ago
$20 million deal: Tabula Rasa reaches agreement to buy Australian med tech company
The proposed purchase of medication safety technology company DoseMe by Tabula Rasa consists of a upfront cash payment of $10 million, and a potential additional $10 million payment in stock and cash.
- GlobeNewswire•2 months ago
Detailed Research: Economic Perspectives on Honeywell International, Tabula Rasa Healthcare, El Pollo Loco, Acceleron Pharma, vTv Therapeutics, and 22nd Century Group — What Drives Growth in Today's Competitive Landscape
NEW YORK, Dec. 03, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- GlobeNewswire•2 months ago
Tabula Rasa HealthCare to Host Investor and Analyst Day on December 4, 2018
MOORESTOWN, N.J, Nov. 27, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced.
- GuruFocus.com•2 months ago
Tabula Rasa Healthcare Inc (TRHC) CEO Calvin H Knowlton Bought $487,500 of Shares
CEO of Tabula Rasa Healthcare Inc (NASDAQ:TRHC) Calvin H Knowlton bought 7,500 shares of TRHC on 11/12/2018 at an average price of $65 a share.
- GlobeNewswire•2 months ago
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
MOORESTOWN, N.J., Nov. 14, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today.
- Zacks•2 months ago
CPSI or TRHC: Which Is the Better Value Stock Right Now?
CPSI vs. TRHC: Which Stock Is the Better Value Option?
- GlobeNewswire•2 months ago
Tabula Rasa HealthCare Acquires Cognify an Integration HealthCare Technology Company
Delivering optimal business performance and outcomes through integrated technology services to senior care organizations and PACE MOORESTOWN, N.J., Nov. 08, 2018 -- Tabula.
- GlobeNewswire•2 months ago
TRHC and Landmark Announce Expansion of MedWise Medication Risk Mitigation Study
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, and Landmark Health (“Landmark”), an industry leader of in-home, risk-based medical care, today announced an expansion of a pilot program using MedWise™, a proprietary software designed to identify medication risk and prevent drug-related adverse outcomes. A phase I pilot study was designed to compare healthcare resource utilization and costs between a control group and a MedWise intervention group.
- Zacks•3 months ago
Tabula Rasa Healthcare (TRHC) Lags Q3 Earnings Estimates
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3.70% and 2.73%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•3 months ago
Tabula Rasa Healthcare: 3Q Earnings Snapshot
On a per-share basis, the Moorestown, New Jersey-based company said it had net income of 47 cents. Earnings, adjusted for one-time gains and costs, came to 26 cents per share. The results fell short of ...
- GlobeNewswire•3 months ago
Tabula Rasa HealthCare Announces Third Quarter 2018 Operating Results
Third Quarter 2018 Revenue of $54.4 million, growth of 66%; 2018 Revenue Guidance Increased MOORESTOWN, N.J., Nov. 06, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”).
- GlobeNewswire•3 months ago
Tabula Rasa HealthCare Appoints New Member to its Board of Directors
Tabula Rasa HealthCare, Inc. (TRHC), a healthcare technology company advancing the field of medication safety, appointed Kathrine O’Brien to its Board of Directors. The appointment occurred at TRHC’s meeting of the Board of Directors held on November 2, 2018 and was effective immediately. Ms. O’Brien is a recognized consumer packaged goods (CPG) executive with 30 years of experience.
- GlobeNewswire•3 months ago
TRHC Praises Signing of SUPPORT for Patients and Communities Act
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, applauds the signing into law of the SUPPORT (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment) for Patients and Communities Act. One of the major policy changes in the new law, which became effective upon signing, will require Medicare Part D plan sponsors to adopt Medication Therapy Management (MTM) programs for seniors determined to be “at risk” for prescription drug abuse by year 2021. The current law allows sponsors to voluntarily adopt MTM services.
- Zacks•3 months ago
Tabula Rasa Healthcare (TRHC) Earnings Expected to Grow: Should You Buy?
Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire•3 months ago
Tabula Rasa HealthCare’s CareKinesis Division Successfully Launched Medication Risk Management and Pharmacy Services for Rocky Mountain PACE
Tabula Rasa HealthCare® (TRHC), a healthcare technology company advancing the field of medication safety, President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA announced that TRHC subsidary CareKinesis® has begun to provide its comprehensive PACE medication risk management services to Rocky Mountain PACE, a program of Rocky Mountain Health Care Services (RMHCS), based in Colorado Springs, CO.
- GlobeNewswire•3 months ago
Factors of Influence in 2018, Key Indicators and Opportunity within Tabula Rasa Healthcare, Interpublic Group of Companies, Travelport Worldwide, Weight Watchers International, vTv Therapeutics, and Ulta Beauty — New Research Emphasizes Economic Growth
NEW YORK, Oct. 24, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
